Gene Query: ANKH

Dataset Description Geneva Score
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 80.19
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 80.19
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 69.68
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 68.43
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 68.18
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 66.45
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 66.14
Paxillin regulates genomic networks in prostate cancer [C4-2] 65.21
AR-independent prostate cancer is sustained through FGF signaling 53.14
Irf9 function in immunity in mouse 52.97
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 52.97
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 48.98
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 48.19
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 48.19
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 48.07
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 47.76
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 45.83
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 44.95
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 41.37
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 38.95
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 38.8
Nutritional control of protein translation 37.86
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 37.84
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 37.84
Gene expression profiling of human and murine in vitro muscle differentiation 37.3
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 36.47
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 35.96
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 34.1
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 33.39
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 33.39
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 33.17
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 32.66
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 32.23
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 31.76
Tumor exosome integrins determine organotropic metastasis 30.52
hnRNP C is a key regulator of protein synthesis in mitosis 28.44
RNA-seq of tumor cells following angiopellosis extravasation 27.91
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 27.57
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 26.48
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 26.17
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 26.17
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 26.05
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 26.05
Role for citron kinase in prostate cancer growth 26.01
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 25.35
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 25.26
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 25.17
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 24.62
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 24.57
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 24.44
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 24.39
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 24.32
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 24.32
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 24.29
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 24.0
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 23.95
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 23.83
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 23.65
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 23.64
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 23.54
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 23.41
Developmental stage specific chromosome architecture in human erythroid cells 23.41
Expression level comparison under dividing and quiescent states in human primary fibroblasts 23.37
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 23.29
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 23.14
Inhibition of TNBC metastasis by Gpx1 23.1
RNAseq Analysis in glioblastoma cells treated with Mepazine 23.06
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 22.6
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 22.48
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 22.38
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 22.32
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 22.24
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 21.82
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 21.44
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 21.31
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 21.15
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 21.11
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 21.05
Generation of trichogenic adipose-derived stem cells by expression of three factors 20.92
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 20.81
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 20.81
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 20.64
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 20.53
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 20.5
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 20.5
Transcriptome wide analysis of classically and alternatively activated macrophages 20.07
Generation of KRAS signatures using immortalized isogenic lung cells. 19.96
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 19.96
RNA sequencing of BT142 and TS603 cell lines 19.92
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 19.92
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 19.83
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 19.74
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 19.58
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 19.32
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 19.16
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 19.01
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 19.01
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 18.86
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 18.53
IL-33 activates tumor stroma to promote intestinal polyposis 18.38
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 18.3
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 18.14
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 18.1
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 18.0
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 17.98
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 17.93
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 17.54
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 17.52
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 17.51
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 17.51
BCL11B 17.5
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 17.29
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 17.29
RNA sequencing of matched nephrectomy samples [RNA-seq] 17.21
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 17.21
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 17.11
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 16.93
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 16.77
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 16.77
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 16.74
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 16.66
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 16.48
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 16.07
HNRNPL and its RNA Targets in Prostate Cancer 15.78
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 15.78
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  15.45
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 15.44
WRN knockout effects upon gene expression in SW48 and OVK18 15.43
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 15.14
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 15.12
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 15.03
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 15.03
Mutational landscape of splicing genes and functional consequences across 33 cancer types 14.98
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 14.92
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 14.87
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 14.82
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 14.8
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 14.69
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 14.66
Transcriptomic and gene ontology profiling of the human corneal cell types 14.65
Co-regulation of splicing by Rbfox1 and hnRNP M 14.65
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 14.65
Transcriptomic analysis of the HOTAIR-regulated genes 14.6
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 14.49
Paxillin regulates genomic networks in prostate cancer [LNCaP] 14.48
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 14.44
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 14.44
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 14.38
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 14.27
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 14.27
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 14.1
snRNAs as regulators of alternative splicing 14.08
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.05
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 14.0
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 13.96
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 13.95
Lipid degradation promotes prostate cancer cell survival 13.91
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 13.9
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 13.9
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 13.87
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 13.84
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 13.81
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 13.68
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 13.63
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 13.57
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 13.57
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 13.46
4sU-seq of HFF exposed to salt and heat stress 13.41
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 13.33
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 13.29
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.28
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 13.13
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 13.06
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 13.04
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 12.99
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 12.92
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 12.92
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 12.85
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 12.81
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 12.81
Role of microRNAs in the interaction between Salmonella and the host cell 12.8
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 12.79
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 12.78
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 12.77
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 12.72
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 12.71
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 12.68
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 12.66
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 12.65
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 12.65
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 12.6
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 12.6
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 12.54
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 12.5
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 12.48
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 12.48
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 12.48
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 12.42
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 12.31
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 12.27
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 12.22
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 12.22
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 12.2
Transcriptome of Stabilin-1 siRNA transfected human monocytes 12.18
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 12.15
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 11.91
Cajal bodies are linked to genome conformation [RNA-Seq] 11.89
Cajal bodies are linked to genome conformation 11.89
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 11.87
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 11.82
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 11.81
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 11.78
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 11.77
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 11.76
Gene expression changes in human melanoma cell lines compared to primary melanocytes 11.71
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 11.71
Pharmacologic inhibition of STAT5 in AML 11.7
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 11.64
RNAseq analysis of ESRP regulated splicing events in prostate cancer 11.61
Uridylation by TUT4 and TUT7 marks mRNA for degradation 11.58
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 11.5
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 11.5
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 11.38
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 11.35
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 11.28
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 11.22
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 11.22
RNA-seq analysis of control and Myc-induced U2OS cells 11.2
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 11.12
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 11.06
The cohesin complex prevents Myc-induced replication stress 11.03
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 11.03
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 11.02
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 10.89
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 10.89
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 10.88
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 10.87
Intrahepatic MAIT cell gene expression revealed by RNA-seq 10.84
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 10.83
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 10.81
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 10.81
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 10.79
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 10.79
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 10.7
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 10.63
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 10.63
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 10.63
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 10.62
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 10.61
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 10.6
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 10.51
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 10.51
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 10.35
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 10.33
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 10.31
Next Generation Sequencing of human SMA and healthy control Motor Neurons 10.29
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 10.25
Gene expression profile in breast cancer cell lines using RNA sequencing 10.25
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 10.25
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 10.22
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 10.21
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 10.2
Measure transcript integrity using RNA-seq data 10.18
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 10.17
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 10.15
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 10.09
Identification of global regulators of T-helper cell lineage specification 10.09
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 10.09
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 10.03
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 9.94
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 9.9
SNHG5 siRNA knock down in HCT116 cells 9.86
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 9.8
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 9.79
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 9.78
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 9.77
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 9.69
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 9.66
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 9.64
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 9.64
Gene expression analysis of the impact of TDP-43 knockout in human cells. 9.63
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 9.61
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 9.59
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 9.56
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 9.53
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 9.49
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 9.47
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 9.44
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 9.42
circNFIB suppresses lymphatic metastasis of pancreatic cancer 9.39
RNA-seq melanoma 9.22
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 9.21
Global gene expression profile of dasatinib-resistant RCH-ACV cells 9.06
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 8.87
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 8.79
Investigation about fibroblasts of different origins in culture 8.77
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  8.71
RNA-sequencing of human tendon after injury 8.71
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 8.67
Chromatin landscape of human visceral and subcutaneous adipocytes 8.5
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 8.47
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 8.47
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 8.46
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 8.34
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 8.33
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 8.32
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 8.24
Fusion discovery in breast cancer cell line 8.23
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 8.22
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 7.97
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 7.88
Macrophage Ad5f35 M2 Challenge 7.8
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 7.68
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 7.64
Fibroblasts in cholesteatoma activate osteoclasts. 7.6
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 7.59
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 7.59
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 7.49
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.45
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 7.43
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 7.35
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.29
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 7.27
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 7.13
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 7.08
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 6.94
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 6.91
Transcriptome analysis of CNS leukemia 6.91
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.87
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 6.84
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 6.82
ARID1A and ARID1B loss in HCT116 and TOV21G cells 6.75
Aortic Valve Tissue: Stenosis vs. Sclerosis 6.72
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 6.52
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 6.52
Changes in human endometrial gland transcriptome over the window of implantation 6.42
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 6.41
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 6.41
Expression charcaterization of an internal protocol developed to differentiate RPE cells 6.36
Characterization of human ILC2 subsets 6.3
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 6.16
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.14
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 6.12
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 6.03
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 6.0
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 6.0
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 5.99
RNA-sequencing of healthy human skeletal myocytes 5.96
Next generation sequencing of small RNAs isolated from exosomes in human semen 5.92
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 5.9
An acquired vulnerability of drug resistant melanoma with therapeutic potential 5.9
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 5.72
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 5.7
5.7
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 5.66
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 5.59
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 5.59
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 5.59
A549 cell transcriptome responses to infection with H7N9 influenza virus 5.57
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 5.56
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.54
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 5.52
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 5.47
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 5.47
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 5.41
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 5.33
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 5.28
Metastasis in triple-negative breast cancer 5.28
Zika virus infection reprograms global transcription of host cells to allow sustained infection 5.26
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 5.23
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 5.21
Impact on erythroid progenitor type on erythroid differntiation 5.2
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 5.19
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 5.19
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.17
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 5.1
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 5.1
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.09
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.09
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.88
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 4.81
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 4.81
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 4.67
Regulation of highly expressed hCINAP on translatome 4.47
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 4.47
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 4.38
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 4.29
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.24
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 4.13
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.96
RNA seq_PDX2_SHP099 3.81
mRNA sequencing of oropharyngeal cancer cell lines 3.8
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 3.78
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.66
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 3.66
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 3.64
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 3.62
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.45
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 3.44
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 3.44
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.41
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 3.39
Efficient derivation of microglia-like cells from human pluripotent stem cells 3.38
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 3.36
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 3.34
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 3.34
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.34
Transcriptome Profiling of Human Primary Monocytes 3.32
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.29
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 3.26
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 3.26
Human Treg IFNg/IL-10 subpopulations 3.19
MARCKS and lnc-MARCKS act as inflammation regulators 3.18
Transcriptome-wide identification of CELF2 functional targets in T cells 3.18
Specific molecular signatures underlie response to decitabine in CMML 3.06
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 3.06
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.03
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 3.02
Human islets of varying quality: the good, the (not so) bad and the ugly 3.0
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 2.9
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.75
Gene expression profile of CRC-derived HILEC 2.75
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.61
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 2.57
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 2.55
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.49
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.44
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 2.38
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.33
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 2.28
The DNA methylation landscape of human melanoma 2.24
The DNA methylation landscape of human melanoma [RNA-Seq] 2.24
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.21
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.13
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.01
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.0
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.99
Modeling Familial Cancer with iPSC Approaches 1.89
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.88
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.86
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.83
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 1.81
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.74
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.71
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.69
Identification of the role of polydom in neurofibromas 1.63
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.63
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.62
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.6
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.58
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.58
naive T cell heterogeneity after neonatal thymectomy 1.56
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.52
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.42
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 1.34
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.33
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.33
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.29
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.25
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.25
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 1.24
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.22
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.19
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 1.12
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 1.12
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 1.03
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.02
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.02
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 0.94
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.9
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.9
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.9
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.86
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 0.84
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.82
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 0.81
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 0.81
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.79
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.79
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 0.73
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.72
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.7
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.69
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.62
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.61
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.61
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 0.59
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.52
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.45
Transcriptomic analysis of human macrophages in 3D 0.43
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.32
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.26
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.21
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.19
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.13
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.12
Transcriptional responses of melanoma cells to BRAF inhibition 0.08
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.07
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation